This would be extremely instructive since a link between PGRMC1, estradiol/estradiol receptor and breast cancer progression was evidenced in other reports that relied on downregulation [34] or overexpression [29] of PGRMC1, and are therefore not challenged by our study. The gene discussed is ESR1; the disease is breast carcinoma.